Premier Alternatives

Suvretta Capital Management

Hedge fund · New York, New York

Suvretta Capital Management is a hedge fund based in New York, New York. Founded in 2011 3 portfolio companies are on record.

AUM
$7.9B
Portfolio companies
3
Recorded deals
—
Last investment
—

Suvretta Capital Management key facts

  • Suvretta Capital Management is a hedge fund based in New York, New York with 3 tracked portfolio companies.
  • Notable positions include VeraDermics (NYS: MANE), connectRN, Avalyn Pharma.
  • The team roster lists 7 people.
  • Suvretta Capital Management reports $7.9B in regulatory assets under management across 3 private funds, per its SEC Form ADV (2026-03).

About Suvretta Capital Management

Founded in 2011

Investment focus

Its SEC Form ADV lists $7.9 billion in regulatory assets under management across 3 private funds (Mar 2026).

Suvretta Capital Management portfolio at a glance

3 portfolio companies are on record for Suvretta Capital Management: VeraDermics (NYS: MANE), connectRN and Avalyn Pharma.

Suvretta Capital Management team

7 people are on record at Suvretta Capital Management: 3 managing partners, 1 analyst and 3 others. Senior names include Alex Rabodzey (Managing Director), Amanda Birdsey-Benson (Managing Director) and David Friedman (Managing Director). 7 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Suvretta Capital Management at the SEC

Form ADV · 2026-03 · CRD 165153
Regulatory AUM
$7.9B
Private fund assets
$7.8B
Private funds
3 · 3 hedge
Staff
23
Registered office
NEW YORK, NY
SEC status
Approved

Discloses a disciplinary history on Form ADV.

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SUVRETTA CAPITAL MANAGEMENT, LLC).

Free account
See more of the book
  • ·Watchlist + alerts for Suvretta Capital Management's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

3 companies · priced for members
CompanyValuationRole
VeraDermics (NYS: MANE)▮▮
connectRN▮▮
Avalyn Pharma▮▮
All 3 companies — valuations, dates and lead flags are a member feature
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
7 people on record — 7 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Suvretta Capital Management

What companies does Suvretta Capital Management invest in?
Suvretta Capital Management has 3 recorded portfolio companies, including VeraDermics (NYS: MANE), connectRN, Avalyn Pharma.
What is Suvretta Capital Management's AUM?
Suvretta Capital Management manages approximately $7.9B in assets.